Skip to content

An open-label phase I/II, single-center, interventional singlearm basket trial of UKT-CART19.1 in patients with relapsed/refractory autoimmune diseases

Status
Not yet recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-519491-60-00
Enrollment
36
Registered
2026-08-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ANCA associated vasculitis (AAV), Immune thrombocytopenic purpura (ITP), Inflammatory idiopathic Myositis (IIM), Multiple sclerosis (MS), Pemphigus vulgaris (PV), Rheumatoid arthritis (RA), Systemic sclerosis (SSc)

Interventions

None listed

Sponsors

Universitaetsklinikum Tuebingen AöR
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Aug 15, 2026